Tenofovir & Emtricitabine Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 300 mg + 200 mg
Reference Brands: Truvada (USA/EU/UK), Descovy (USA/EU/UK)
Category: Anti Viral
The salt combination Tenofovir / Emtricitabine is used for the treatment of Hiv, Hepatitis B Virus, Hiv Infection and other conditions. Tenofovir & Emtricitabine Tablets is available in Tablets and strengths such as 300 mg + 200 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Tenofovir & Emtricitabine Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Tenofovir & Emtricitabine Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Tenofovir / Emtricitabine is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms: · HIV · Hepatitis B Virus · HIV Infection Tenofovir / Emtricitabine Working, Mechanism of Action and Pharmacology Tenofovir / Emtricitabine improves the patient's condition by performing the following functions: · Blocking the activity of a viral enzyme. · Lowering the growth and decreasing the amount of HIV virus in the body.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Tenofovir and Emtricitabine are used together for the treatment of HIV-1 infection as part of combination antiretroviral therapy. This combination is also used for HIV pre-exposure prophylaxis (PrEP) to reduce the risk of acquiring HIV in high-risk individuals.
It is made from two active ingredients: tenofovir disoproxil fumarate or tenofovir alafenamide (depending on formulation) and emtricitabine. Both are nucleoside/nucleotide reverse transcriptase inhibitors that work by blocking HIV viral replication.
The most commonly known trade name for the combination is Truvada. Another brand name exists when tenofovir alafenamide is used, marketed as Descovy.
Truvada and Descovy were originally developed and manufactured by Gilead Sciences. Many pharmaceutical companies now produce approved generic versions worldwide.
The generic name is tenofovir (either disoproxil fumarate or alafenamide) and emtricitabine fixed-dose combination.
Brand names include Truvada and Descovy, along with multiple generic equivalents available across global markets.
It is manufactured by several WHO-GMP and FDA/EMA-approved pharmaceutical companies across India, the United States, Europe, and other regions, depending on the brand or generic version.
Related Products
Maraviroc
Strength:
150 mg, 300 mg, 20 mg
Form: Tablets / Oral solution
Reference Brands: Selzentry (USA), Celsentri (EU)
View Details
Raltegravir
Strength:
100mg, 400 mg, 600mg
Form: Tablets
Reference Brands: Isentress (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
